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The neuronal localization of glutamate and phencyclidine (PCP) receptors was evaluated in the cerebral cortex and hippocampal formation 
of rat CNS using quantitative autoradiography. Scatchard analysis of [3H]glutamate binding in the cortex (layers I and II and V and VI) showed 
no difference in the total number of binding sites (Bm~x) or apparent affinity (Kd) 1 week, 1 month and 2 months following unilateral ibotenate 
lesions to nucleus basalis of Meynert (nbM) compared to the non-lesioned side. Quisqualic acid displacement of [3H]glutamate in layers I and 
II, 1 week following nbM destruction, revealed both high- and low-affinity binding sites (representing the quisqualate (QA) and 
N-methyI-D-aspartate (NMDA) sites, respectively). Compared to the control side, there was no difference in binding parameters for either 
of the receptor sites. In similarly lesioned animals, the NMDA receptor was specifically labelled with [3H]glutamate and the associated PCP 
receptor labelled with [3H]N-(1-[2-thienyl]cyclohexyl)3,4-piperidine ([3H]TCP) in adjacent brain sections. For both receptors, there was no 
change in the total number of binding sites in the cortex following destruction of nbM. On the other hand, virtually all binding to NMDA 
and PCP receptors was eliminated following chemical destruction of intrinsic cortical neurons. These results suggest that the NMDA/PCP 
receptor complex does not exist on the terminals of cortical cholinergic afferents. One week after knife cuts of the glutamatergic entorhinal 
pathway to the hippocampai formation only an approximate 10% reduction of NMDA and PCP receptors was seen in the dentate gyrus. 
Conversely, selective destruction of the dentate granule cells using colchicine caused a near identical loss of NMDA and PCP receptors (84% 
vs 92% respectively). It is concluded from these experiments that glutamate and PCP receptors exist almost exclusively on neurons intrinsic 
to the hippocampal formation and that no more than 10% of NMDA and PCP receptors exist as autoreceptors on glutamatergic terminals. 
INTRODUCTION 
Glu tamate  is a ma jo r  excitatory neurot ransmit ter  in 
the mammal ian  central  nervous system which activates at 
least 4 recep tor  subtypes 75. Due  to the availabili ty of 
selective antagonists  for exper imenta l  analysis, the N- 
methyl -o-aspar ta te  ( N M D A )  receptor  has been most 
thoroughly investigated.  N M D A  receptors  occur in high- 
est densi ty in subregions of  the h ippocampal  format ion 
and in layers I and II  of the cerebral  cortex 19'45. 
Act ivat ion  of this receptor  seems to be necessary for the 
induction of long-term potent ia t ion 24'46 and may be 
impor tan t  in the deve lopment  of seizures 1°A5'26 as well as 
neuronal  destruct ion caused by hypoxiaJischemia 23'5s'69 
and hypoglycemia  74. N M D A  receptors  have also been 
shown to be decreased in the cerebral  cortex 2° and 
h ippocampal  format ion  21'54 of  pat ients  with dement ia  of 
the Alzhe imer  type (DAT) .  
The  dissociative anesthetics (e.g. phencyclidine and 
ke tamine)  are a unique class of  drugs which are thought 
to interact  with the N M D A  receptor .  Electrophysiolog-  
ically, these drugs have been shown to block the 
activation of the N M D A  receptor  in the spinal cord and 
cortex 13,33'65. The  dissociative anesthet ics  also inhibit  the 
induction of long- term poten t ia t ion  62 and N M D A - i n -  
duced neuronal  degenera t ion  5°. Drugs  like PCP and 
ke tamine  appear  to act as non-compet i t ive  inhibitors of  
the N M D A  receptor  25'41 and probab ly  exer t  their  effects 
at an allosteric site on the recep tor  complex 35. Suppor t  
for this concept  comes from binding studies demonst ra t -  
ing that  the dissociative anesthet ic  binding sites possess a 
distr ibution identical  to that  of the N M D A  receptor  in 
the rat  forebrain  4°. The  N M D A  receptor  complex has 
also been solubil ized from rat  and pig brains 42 and 
expressed in Xenopus oocytes in jected with e i ther  rat  
brain 3°,67 or mouse neu rob l a s toma-Ch inese  hamster  
brain hybrid 32 m R N A .  In both instances the N M D A  
receptor  complex displayed pharmacologica l  and physi- 
ological proper t ies  similar to those seen in both mem- 
brane and tissue prepara t ions .  
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Whi le  m u c h  da ta  has  recent ly  b e e n  ga the red  concern-  
ing the  pha rmaco log ica l  and behav io ra l  in te rac t ions  
b e t w e e n  the  two  sites,  l i t t le is known  about  thei r  
neu rona l  local iza t ion.  In  the  ce rebra l  cor tex ,  N M D A  
s t imula tes  the  re lease  o f  ace ty lchol ine  34, possibly by 
s t imula t ion  o f  the  t e rmina l s  of  neu rons  or ig ina t ing  f rom 
the  subcor t ica l  nuc leus  basalis of  M e y n e r t  (nbM)  27'7°. 
D r u g s  l ike P C P  b lock  this e n h a n c e m e n t  34. In the  h ippo-  
campus ,  N M D A  recep to r s  m a y  exist  presynapt ica l ly  on 
g lu t ama te rg ic  t e rmina l s  6'8. 
In o r d e r  to d e t e r m i n e  w h e t h e r  g lu t ama te  and P C P  
recep to r s  a re  loca ted  on  the  p resynap t ic  t e rmina l s  of  
chol inerg ic  o r  g lu t ama te rg ic  neu rons  o r  on pos tsynapt ic  
e l e m e n t s  intr insic to  the  cor tex  and h ippocampus ,  we 
have  c o n d u c t e d  a u t o r a d i o g r a p h y  of  bo th  [3H]glutamate  
b inding  to  N M D A  recep to r s  and [3H]TCP b inding  to 
d issocia t ive  anes the t i c  sites in a ser ies  o f  expe r imen ta l ly  
l e s ioned  animals .  In one  g roup ,  animals  r ece ived  unilat-  
era l  ibo ten ic  acid lesions to n b M  and b inding to bo th  
r ecep to r s  was ana lyzed  in cor tex.  In the  second  group  of  
an imals ,  axon  spar ing  lesions using ibo ten ic  acid were  
m a d e  in the  cor t ica l  p ro j ec t i on  zones  of  n b M  and 
subsequen t  analysis of  r ecep to r  b inding in the  cor tex  was 
car r ied  out .  W e  have  also l es ioned  the  g lu tamate rg ic  
e n t o r h i n o d e n t a t e  pa thway  72, since this is a un id i rec t iona l  
p ro j ec t i on  6°'63 and any subsequen t  dec rease  in r ecep to r  
b inding  in the  den t a t e  gyrus wou ld  imply a p resynapt ic  
loca l iza t ion  o f  the  r ecep to r  complex .  Conver se ly ,  we 
have  d e s t r o y e d  granu le  cells o f  the  den ta t e  gyrus,  using 
the  a lka lo id  colchic ine ,  to d e t e r m i n e  what  p ropo r t i on  of  
r ecep to r s  a re  pos tsynapt ic .  Colch ic ine  disrupts  mic ro tu-  
bu la r  f o r m a t i o n  and,  in the  h i p p o c a m p a l  fo rma t ion ,  
se lec t ive ly  des t roys  g ranu le  cells TM. 
MATERIALS AND METHODS 
Surgery 
Adult male Sprague-Dawley rats weighing approximately 200 g 
were used in all surgical procedures. Animals were anesthetized 
with xylazine (5 mg/kg) and ketamine (80 mg/kg) and surgery 
conducted with the animal's head secured firmly in a Kopf 
stereotaxic apparatus. For all surgical procedures, the incisor bar 
was 2.4 mm below the intra-aural plane. 
Nucleus basalis lesions 
Following placement of the animal in the stereotaxic apparatus, 
the skull was exposed, and a small burr hole was made with a dental 
drill. After removing the bone chip and incising the dura, a 30 gauge 
flat-tipped cannula was lowered into the brain. Ibotenic acid (10 
#g//A dissolved in distilled water and adjusted to pH 7.4 with NaOH) 
was infused at a rate of 1 gl per 8 min 20 s. Each animal received 
a 0.5/A (31.6 nmol) injection to nbM. Some animals received an 
additional 0.5 gl injection of ibotenate into the anterior continuation 
of nucleus basalis at the level of the magnocellular preoptic nucleus. 
Coordinates for nbM were 1 mm posterior and 2.4 mm lateral to 
bregma and 6.6 mm ventral to the surface of the brain. Coordinates 
for magnocellular preoptic nucleus were 0.4 mm posterior and 2.4 
mm lateral to bregma and 8.0 mm ventral to the surface of the brain. 
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A group of 8 rats received sham lesions by lowering the cannula into 
nbM and infusing 0.5 ~tl of 0.9% saline. Animals were allowed to 
survive 1 week, 1 month, or 2 months at which time they were 
decapitated and their brains rapidly removed. The brains were 
quickly frozen on dry ice and stored at -70 °C until use. 
Cortical lesions 
A small hole was drilled 5 mm lateral to bregma. The dura was 
incised and a 30 gauge flat-tipped cannula was lowered 2 mm into 
the brain. Ibotenic acid (1 jug/~l dissolved in distilled H20 and 
adjusted to pH 7.4 with NaOH) was infused at a rate of 1/A per 8 
rain 20 s. Each animal received two 0.375 #l injections (2.37 nmol 
each), one 0.0 mm and the other 1.5 mm posterior to bregma. 
Following a I week survival period, animals were killed, their brains 
removed and frozen until use. 
Entorhinal knife cuts 
As with nbM-lesioned animals, rats were anesthetized, placed in 
a stereotaxic apparatus, an incision was made, and the fascia and 
muscle were retracted. A trench was then drilled in the skull 7 mm 
posterior to bregma extending from near the midline to the origin 
of the temporalis muscle. A razor blade approximately 2 mm wide 
was lowered 6 mm beneath the surface of the brain and moved from 
the midline to the lateral surface of the brain to cut the angular 
bundle and sever the fibers of the perforant pathway, as described 
by Gibbs et al.17. In this study the contralateral hippocampus served 
as control. Animals survived for 1 week at which time they were 
decapitated, their brains removed, frozen quickly on dry ice and 
stored at -70 °C. 
Dentate gyrus lesions 
Surgical preparations were carried out as previously described. 
Following removal of the bone chip the dura was incised. A 30 gauge 
flat-tipped cannula was lowered into the brain, and colchicine, at a 
concentration of 5 ~g/#l (dissolved in distilled water and adjusted to 
pH 7.4), was infused at a rate of 1/A per 8 rain and 20 s. Each animal 
received two 0.5/A injections (12.5 nmol total) of colchicine to the 
dentate gyrus. A rostrai lesion was placed 3.4 mm posterior and 1.1 
mm lateral to bregma and 3.8 mm ventral to the surface of the 
cortex. A caudal lesion was made 4.3 mm posterior and 2.0 mm 
lateral to bregma and 3.7 mm below the cortical surface. In this 
study, animals were allowed to survive for 1 week, then killed and 
their brains removed and frozen at -70 °C until assayed. 
[~H]Glutamate incubation 
On the day of the experiment, the frozen brains were mounted on 
cryostat chucks and equilibrated in the cryostat for one half hour 
prior to cutting. Sections (20 ~M) were then cut and thaw-mounted 
onto gelatin-coated slides. Slides were prewashed for 30 min in 
either ice-cold 50 mM Tris-HC1 buffer with 2.5 mM CaC12, pH 7.4 
or 50 mM Tris-acetate, pH 7.4 and then air dried. Detailed 
saturation and displacement studies of [3H]glutamate binding were 
carried out on all except 14 of the nbM-lesioned brains (see below). 
Saturation studies were carried out in 50 mM Tris-HCl buffer pH 7.4 
with 2.5 mM CaC12 to determine total L-[3H]glutamate binding and 
in 50 mM Tris-acetate pH 7.4, which has been shown to favor 
binding to the NMDA receptor 19. Sections were placed in contain- 
ers with 10 ml buffer containing 45 nM L-[3H]glutamate (22 
Ci/mmol, Amersham) and varying concentrations of non-radioac- 
tive glutamate ranging from 25 nM to 10 ~M. For displacement 
studies, slides were placed in containers with 10 ml of 50 mM 
Tris-HCi buffer pH 7.4 with 2.5 mM CaCl2, 200 nM L-[3H]glutamate 
(spec. act. of 5.23 Ci/mmol) and varying concentrations of quisqua- 
lic acid ranging from 1 nM to 1 mM. 
In 8 nbM-lesioned brains and brains with cortical, entorhinal and 
dentate lesions, NMDA receptor density was determined in sections 
incubated for 45 min in 50 mM cold Tris-acetate, pH 7.4, containing 
200 nM [3H]glutamate (5.23 Ci/mmol, Amersham). Non-specific 
binding was determined in the presence of 1 mM unlabeled 
glutamate. 
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All sections were incubated in duplicate. Following incubation, 
the slides were rapidly rinsed 3 times with 3 ml of the appropriate 
ice-cold buffer, followed by one rinse with a solution of cold 
glutaraldehyde and acetone (1:19 v/v) and rapidly dried under a 
stream of heated air. The total rinse time in this assay did not exceed 
10 s. 
[~H]TCP incubations 
For [3H]TCP binding, sections adjacent to those used for single 
point NMDA receptor determinations were used. Sections were 
washed for 30 min in cold 50 mM Tris-acetate, pH 7.4, and dried. 
Sections were then incubated for 45 min in the same buffer at 4 °C 
containing 1 mM magnesium acetate and 20 nM [3H]TCP (40 
Ci/mmol, New England Nuclear). Magnesium acetate was added to 
the incubation medium, as this has been shown to enhance [3H]TCP 
binding 7. Non-specific binding was determined by incubating sec- 
tions with [3H]TCP in the presence of 20/xM unlabeled PCP. All 
sections were incubated in duplicate. Following incubation, sections 
were washed 3 times, 1 min each in cold buffer and rapidly dried. 
Autoradiography and data analysis 
Sections were placed in an X-ray cassette and apposed to a piece 
of Ultrofilm 3H (LKB). A complete set of radioactive standards was 
co-exposed with each film. Following a 2 week exposure period at 
4 °C, films were developed in D19 (Kodak), fixed and dried. 
Autoradiographic analysis was carried out using a previously 
described method 51. At least 15 densitometric readings were taken 
from each area of interest on each autoradiogram section. Ana- 
tomical correlations were determined using the atlases of Paxinos 
and Watson 53 and of Zilles TM. Scatchard curves were generated from 
saturation data using the program LIGAND 47. Quisqualate dis- 
placement curves were analyzed using the LIGAND program also. 
Readings from each series of lesioned animals were averaged and 
compared to the non-lesioned side using Student's t-test. 
Acetylcholinesterase histochemistry and choline acetyltransferase 
assays 
In 6 nbM-lesioned brains, the frontal poles were dissected and 
assayed for choline acetyltransferase activity (CHAT) according to 
the method of Fonnum 16. Briefly, brain tissue homogenates were 
prepared (5%, w/v) and the enzyme liberated with 0.5% Triton 
X-100. Samples of the homogenate were then incubated in the 
presence of [14C]acetyl-coenzyme-A (acetyl-CoA) and choline 
bromide for 15 min at 37 °C. The reaction was stopped by rapidly 
chilling the incubation tubes and adding 5 ml cold phosphate buffer 
to each tube. The reaction mixtures were added to scintillation vials 
containing toluene, acetonitrile and sodium tetraphenyl boron and 
agitated gently to extract the [14C]acetylcholine reaction product 
into the organic phase. The amount of radioactivity in the organic 
layer was then counted in a Beckman LS8100 scintillation counter. 
Since water does not function as a scintillant, the [14C]acetyl-CoA 
that remained in the aqueous layer was not counted. The number 
of nmol of [14C]acetylcholine produced per mg protein per hour was 
then calculated. 
In nbM-lesioned brains in which detailed saturation and displace- 
ment studies were carried out and in brains which had received 
TABLE I 
Choline acetyltransferase activity in frontal pole of nb M-lesioned rats * 
Values are means + S.E.M. 
nmol substrate/ % 
h r/mg protein reduction 
Non-lesioned side 0.259 + 0.0045 - 
Lesioned side 0.105 + 0.025 62* * 
*n = 6; **P < 0.0005. 
ibotenate lesions to the cortex, 2-4 cryostat sections were obtained 
through the receptor assay region and processed for acetylcholin- 
esterase (ACHE) histochemistry 29. Sections were washed for 1 h in 
cold 0.9% saline and rinsed with distilled water. Sections were then 
incubated for 3 h at 37 °C in Tris-maleate buffer with acetylthio- 
choline as substrate. CuSO~ was included in the reaction mixture to 
complex with the liberated thiocholine. This copper-choline com- 
plex was stained with ammonium sulfate. Following the incubation, 
slides were rinsed in distilled water, dehydrated and coverslipped 
with D.P.X. (BDH Chemicals). Analysis of stained tissue was 
carried out using a Leitz SM LUX microscope. 
RESULTS 
Nucleus basalis lesions 
Verification of nbM lesions at all time points was 
carried out by several tests. In animals in which frontal 
poles were dissected and assayed for CHAT, enzyme 
activity was reduced by 62% on the lesioned side (Table 
I). The extensive reduction of ChAT activity in the 
frontal poles did not, however, ensure a loss of cholin- 
ergic innervation in the somatosensory cortex through 
which sections were taken for autoradiography. To 
determine the extent of cholinergic loss in this region, 
every tenth cryostat section through the region was 
stained for ACHE. A total of approximately 4 sections 
from each animal were stained in this manner. 
Animals receiving single unilateral ibotenic acid injec- 
tions to nbM displayed marked depletion of AChE 
positive reaction product in the ipsilateral neocortex (Fig. 
1). Loss of AChE staining included both motor and 
somatosensory cortices, but abruptly stopped at the 
anterior cingulate gyrus which has been shown to receive 
its cholinergic innervation from the vertical limb of the 
diagonal band an. Animals which received a second lesion 
to the magnoceilular preoptic nucleus showed additional 
depletion of AChE in the basolateral amygdaloid nu- 
cleus. In some animals caudal sections were obtained 
through nbM itself. In these animals loss of ACHE- 
positive neurons was observed in the lesioned nbM. In 
animals that had received sham lesions to the nbM there 
was no apparent decrease of AChE staining (not shown) 
in either cerebral cortex or nbM. 
Scatchard analyses of L-[3H]glutamate binding in Tris- 
HC1 buffer in layers I and II of the somatosensory cortex 
of the non-lesioned side 1 week following surgery 
revealed a single binding site with a Bma x of 18 + 2.1 
pmol/mg protein and K o of 320 + 60 nM (Fig. 2). On the 
lesion side the Bma x w a s  18 + 2.0 pmol/mg protein and 
the Kd 310 + 40 nM. These values were not statistically 
different. Scatchard analyses of L-[3H]glutamate binding 
in layers V and VI, were also carried out (Fig. 3). 
Ipsilaterai to the lesion, [3H]glutamate binding revealed 
a single site with a Bma x of 10 + 3.3 pmoi/mg protein and 
K d of 280 + 56 nM. These values are not statistically 
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Fig. 1. Adjacent cryostat sections taken from nbM-lesioned rat and processed for acetylcholinesterase histochemistry (top) and total 
[3H]glutamate binding (bottom). 
different from the contralateral side in which Bma x 
equalled 12 + 3.8 pmol/mg and K d equalled 300 + 26 
nM. 
While the fiber projections of nbM project to all parts 
of the ipsilateral neocortex 2A2'31'44'55 contralateral pro- 
jections may also exist 68. In an effort to preclude the 
possibility that no side to side changes were observed due 
to an underestimation of the bilaterality of nbM effe- 
rents, the total binding of [3H]glutamate was measured in 
the ipsilateral cortex of rats 1 week following lesions to 
the nbM and compared to total binding in the cortex of 
8 rats which received sham lesions to nbM 1 week 
previously. In the control group, the Bma x (determined in 
Tris-HCl buffer) was 21 + 5.6 pmol/mg protein and the 
Kd 290 + 107 nM. These values were not statistically 
different from those obtained in the cortex ipsilateral to 
nbM lesions. 
Total [3H]glutamate binding in layers I and II and V 
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Fig. 2. Representative Scatchard plot of [3H]glutamate binding in 
cortical layers I and II of rat somatosensory cortex 1 week following 
nbM lesion. Binding assays were carried out in 50 mM Tris-HCl as 
described in Materials and Methods. Each point represents specific 
binding (average of 15 densitometric readings minus readings from 
nearly adjacent sections in the presence of 1 mM glutamate). 
and VI was also evaluated 1 and 2 months following 
unilateral nbM lesions (Fig. 4). At each time point, no 
significant changes were observed in Bma x between the 
lesioned and non-lesioned side in the respective layers. 
There was also no change in affinity constants of 
[3H]glutamate over time (not shown). 
Quisqualic acid displacement of [3H]glutamate has 
been demonstrated to reveal high- and low-affinity sites 
in the rat and human brain 19. The high-affinity quisqua- 
late site is pharmacologically compatible with a combi- 
nation of the ionotropic quisqualate (AMPA, +-a-  
amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid) 
and the quisqualate-sensitive receptor linked to inositol 
6q 
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Fig. 3. Representative Scatchard plot of [~H]glutamate binding in 
cortical layers V and VI of rat somatosensory cortex 1 week 
following nbM lesion. Binding assay was carried out as in Fig. 2. 
phospholipid metabolism 5,75. The low-affinity quisqua- 
late site is pharmacologically and anatomically most 
similar to that of the NMDA receptor. In cortical layers 
I and II ipsilateral to the nbM lesions, there were 
approximately twice the number of low-affinity sites as 
there were high-affinity sites. This proportion was iden- 
tical to that of the non-lesioned side (Fig. 5; Table II). 
Moreover, there was no significant difference in the 
absolute number of high- and low-affinity sites nor was 
there a difference in the affinity of the high (KH) and low 
(KL) affinity sites between the two sides (Table II). 
Since there was no change in total glutamate binding 
up to two months following nbM lesions, single point 
assays on adjacent sections comparing [3H]glutamate 
binding to NMDA receptors and [3H]TCP binding were 
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Fig. 4. Histogram of Bma X values of [3H]glutamate binding one week, one month, and two months following nbM lesions. Bma x values (in 
pmol/mg protein) were determined from Scatchard curves generated from saturation experiments carried out in 50 mM Tris-HC1, and thus 
represent total binding. 
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TABLE II 
Quisqualic acid displacement of [3 H]glutamate binding in cortical layers 1 and H in nb M-lesioned rats * 
Values are m e a n s  + S.E.M. 
g H (riM) K L (pM) B n (pmol) B L (pmol) %H %L 
Non-lesioned side 326 + 199 254 + 47 7.88 + 1.5 9.72 + 1.35 45 55 
Lesioned side 99.57 + 83 131 + 15 7.48 + 0.68 13.5 + 1.5 36 64 
*n=9.  
binding to either receptor in the cortex was observed 
when the lesioned side was compared to the non-lesioned 
side (Table III). 
Cortical lesions 
Analys i s  of  Cresyl  v io le t - s ta ined  cryostat  sect ions 
t aken  th rough  the  les ion site r evea l ed  reg ions  of  neu rona l  
loss w i thou t  t issue necrosis  in 6 bra ins  (not  shown) .  Both  
large-  and  med ium-s i ze  neu rons  w e r e  absent  and re- 
p l aced  by glial e l emen t s .  These  areas  e x t e n d e d  ventra l ly  
b e y o n d  the  cen t ra l  zone  o f  the  lesion and invar iably  
inc luded  layers  V and  VI .  A C h E  staining r e m a i n e d  intact  
in the  ven t ra l  l aminae  o f  the  cor tex  on  sect ions ad jacen t  
to these  used  in b inding  assays. D e n s i t o m e t r i c  analysis 
was thus  conf ined  to layers  V and VI .  W h e n  bound  
va lues  o f  N M D A  and T C P  recep to r s  on the  l es ioned  side 
w e r e  c o m p a r e d  to layers  V and VI  of  the  non- l e s ioned  
side,  a g rea t e r  than  90% reduc t ion  o f  bo th  recep tors  was 
o b s e r v e d  (Table  I I I ) .  
Entorhinal knife cuts 
Eight animals received knife cuts to the angular 
TABLE III 
[3H]Glutamate binding to NMDA receptors and [3H]TCP binding 
following selective cortical and subcortical lesions 
Values are means +_ S.E.M. 
Lesion Receptor 
NMDA [3H]TCP 
(pmol/mg protein) (pmol/mg protein) 
nbM 
Contralateral 2.77 + 0.22 0.25 + 0.01 
Ipsilateral 2.71 + 0.26 0.25 + 0.02 
Cortical 
Contralateral 1.34 + 0.26 0.095 _+ 0.007 
Ipsilateral 0.11 + 0.067** 0.001 + 0.007*** 
Entorhinal 
Contralateral 4.38 + 0.21 0.35 + 0.02 
Ipsilateral 3.99 + 0.26 0.32 _ 0.02* 
Dentate 
Contralateral 4.1 + 0.234 0.25 + 0.022 
Ipsilaterai 0.67 + 0.205*** 0.02 + 0.01"** 
Student's t-test P-values: * < 0.05; ** < 0.01, *** < 0.001. 
bundle. Analysis of Cresyl violet stained cryostat sections 
taken at various dorsoventral levels revealed complete 
separation of the entorhinal cortex from the hippocampal 
formation in approximately the dorsal 3/4 of the hippo- 
campal formation. Due to the nature of the surgery, the 
cut never extended through the most ventral and lateral 
portions of the entorhinal cortex and it is likely that some 
projections arising from pars lateralis remained intact. 
The striate and subicular cortices were also interrupted. 
In no case was there any evidence of damage to the 
hippocampus proper or the dentate gyrus. 
For receptor binding studies, 8 sequential sections 
were obtained from the dorsal hippocampal formation at 
a level where the subregions CA1, CA4 and the dentate 
gyrus could be clearly identified. The first 4 sections were 
assayed for NMDA receptors and the last 4 sections 
assayed for [3H]TCP binding. Densitometric readings of 
the dentate gyrus were taken from these sections in the 
region corresponding to the outer two thirds of the 
molecular layer. 
Analysis of [3H]glutamate binding to NMDA receptors 
in the control dentate gyrus 1 week following knife cuts 
revealed that there were 4.38 + 0.21 pmol/mg protein 
glutamate bound. Ipsilateral to the lesion there was 3.99 
+ 0.26 pmol/mg protein glutamate bound. The difference 
between the lesioned and non-lesioned side was 9%, but 
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Fig. 5. Quisqualic acid displacement curve of [3H]glutamate binding 
in cortical layers I and II one week following ibotenate  les ions  to 
nbM. Competition experiments were conducted as described in text 
and curves generated using the computer-program LIGAND. Each 
point represents the averaged specific binding obtained from 9 
lesioned animals. 
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Fig. 6. Low power view of Cresyl violet-stained sections of the hippocampal formation. Left figure,- control side; right figure, lesion 
(contralateral) side 1 week following injection of colchicine. Note depletion of granule cells in both blades of the dentate gyrus. 
not significant. Binding of [3H]TCP also revealed 9% 
reduction of binding on the lesioned side, which was 
statistically significant (Table III). 
Dentate gyrus lesions 
One week following application of colchicine, a near 
total loss of dentate gyrus granule cells was observed on 
visual inspection. Microscopic visualization under low 
power supported this finding and also showed marked 
inflammatory reaction in the region where dentate 
granule cells existed (Fig. 6). Due to the loss of neurons, 
there was a narrowing of the space between the stratum 
oriens of CA1 and stratum oriens of CA4, as well as a 
reduction in the distance between CA1 and the dorsal 
thalamus. 
Four sequential sections in each brain were assayed for 
NMDA receptors and 4 sequential sections assayed for 
[3H]TCP binding. As with animals with entorhinal knife 
cuts, densitometric readings of the dentate gyrus were 
taken from these sections in the outer two-thirds of the 
molecular layer. When the amount of [3H]glutamate 
binding to the NMDA receptor on the lesioned side was 
compared to the non-lesioned side of the dentate gyrus, 
an 84% reduction was observed (Table III). Similarly, 
[3H]TCP binding was reduced approximately 92% in the 
colchicine-treated dentate gyrus compared to the untrea- 
ted side (Table III). 
DISCUSSION 
In this study the neuronal localization of both NMDA- 
sensitive glutamate and dissociative anesthetic receptors 
was investigated. Previous studies have indicated that 
glutamate and compounds like PCP and ketamine regu- 
late the release of cortical 34 and striatal acetylcholine 59. 
Furthermore both receptor types are known to be 
decreased in the brains of patients who have died with 
D A T  2°'21"39'54. Most of the acetylcholine in the cortex is 
released from the terminals of nbM neurons 28. Since the 
nucleus basalis projects widely to the entire cortical 
m a n t l e  2'12'31'44 and shows marked cell loss in DAT n'73 it 
was thought that at least some of the cortical NMDA and 
dissociative anesthetic receptors might be located on nbM 
terminals. Thus, the loss of NMDA receptors could be 
secondary to the degeneration of cholinergic terminals. 
Following unilateral lesions to the nucleus basalis no 
changes were observed in either the total number of 
glutamate binding sites or their affinities when side to 
side comparisons were made at one week, two weeks or 
two months following surgery. Moreover, displacement 
studies showed that the proportion of high- and low- 
affinity quisqualate binding sites remained constant fol- 
lowing nbM lesions. The possibility that there was an 
inadequately placed lesion was ruled out by analyzing the 
efficacy of the lesion using AChE histochemistry. In 
addition, comparison of glutamate binding in nucleus 
basalis-lesioned rats to binding in sham-lesioned rats 
indicated no change in either the Bma x o r  Ko of glutamate 
binding. The values of [3H]TCP binding in the cortex, 
ipsilateral to the lesion were not significantly different 
from the contralateral cortex and were virtually identical 
to levels of binding seen in the cortex of normal rats 4°. 
These findings indicate that neither cortical NMDA nor 
[3H]TCP-labeled receptors exist on presynaptic terminals 
of cholinergic neurons originating in nbM. 
An alternative hypothesis to the presynaptic localiza- 
tion of NMDA and TCP receptors is that they exist on 
neurons intrinsic to the cerebral cortex, lbotenic acid 
lesions made in the cortex resulted in a greater than 90% 
reduction of both NMDA (92%) and PCP (99%) binding 
sites. Ibotenic acid is a rigid heterocyclic analogue of 
glutamate known to make axon-sparing lesions 56. In this 
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study, only regions in which AChE staining remained 
intact were analyzed, further strengthening the argument 
that the receptor loss was not due to degeneration of 
ascending cholinergic terminals. The near total reduction 
in NMDA and PCP receptors indicates that, at least in 
the cortex, the NMDA receptor complex exists on 
intrinsic neurons. 
Unlike the cerebral cortex, physiological a and bio- 
chemical 6 studies in the hippocampal formation have 
suggested that NMDA receptors exist as presynaptic 
autoreceptors, regulating the release of glutamate from 
excitatory amino acid nerve endings. To test this latter 
possibility, binding to both NMDA and dissociative 
anesthetic receptors was studied in the outer two-thirds 
of stratum moleculare of the dentate gyrus following 
knife-cut lesions to the entorhinodentate pathway and 
following selective destruction of dentate granule cells 
using colchicine. The dentate gyrus contains a high 
density of both NMDA and PCP receptors 19'4°. The 
entorhinal cortex is the origin of a unidirectional projec- 
tion system 6°'63 which provides the major glutamatergic 
innervation to the dentate gyrus 72. Lesions to this 
pathway have been shown to result in reduction of 
markers specific for glutamate terminals 48,61. 
One week following knife cuts to this pathway a small 
(9%) but significant reduction of [3H]TCP binding was 
observed. An equally small reduction of NMDA recep- 
tors was measured, but this was not significant. This 
disparity may be due to the increased variance seen in the 
NMDA assay. These findings are consistent with those 
recently reported by Ulas et al. 66 who demonstrated a 
statistically not significant 'trend towards reduction in 
NMDA receptor binding levels' in the outer two-thirds of 
stratum moleculare 1-7 days following ipsilateral ento- 
rhinal cortex ablation. On the other hand, the small but 
significant reduction in TCP binding we observed con- 
trasts with the absence of change in binding of [3H]MK- 
801 to the PCP site noted by Bekenstein et al. following 
unilateral entorhinal cortex lesions. This disparity may be 
due to several factors. Bekenstein et al. 1 removed 
afferent input to the dentate gyrus with electrolytic 
lesions of the entorhinal cortex which may have spared 
some cells of origin of the entorhinodentate pathway. 
Additionally, in analyzing their autoradiograms, they 
densitometrically averaged the area of the entire dorsal 
blade of the dentate gyrus (which includes the granule 
cell layer) while we measured a region limited to the 
outer two-thirds of the dorsal blade of the dentate gyrus. 
As the reduction we report in PCP receptor number is 
small, it is possible that this reduction might have been 
missed due to the dilutional effect of analyzing a larger, 
less homogenous region. 
Destruction of the granule cells, on the other hand, 
resulted in an almost 90% reduction of both receptors. 
Similar but less marked (50-60%) reduction in [3H]MK- 
801 binding was reported by Bekenstein et al. following 
colchicine administration to the dentate gyrus 1. Their 
study, however, used smaller amounts of colchicine per 
lesion which likely resulted in less complete destruction 
of the granule cell and subsequently more residual 
binding. Taken together, it appears that nearly all of the 
NMDA and TCP receptors in the dentate gyrus exist on 
granule cell dendrites and that no more than 10% exist 
presynaptically as autoreceptors on entorhinodentate 
glutamate terminals. A predominantly postsynaptic lo- 
calization of NMDA receptors has also been shown to 
occur in the CA1 region of the rat hippocampal for- 
mation 9. 
In a previous study by Werling and Nadler, significant 
reductions (about 45%) of binding to glutamate receptors 
in the dentate gyrus were not observed until almost 3 
weeks following destruction of the entorhinal cortex 71. 
Werling and Nadler, however, used fresh membrane 
preparations for binding assays. Since there is a large 
population of non-NMDA glutamate binding sites de- 
tectable in fresh but not frozen tissue 14, it is likely that the 
receptors they described were non-NMDA. Neverthe- 
less, since it had been shown that dendritic spines 
degenerated in the dentate gyrus 1 week following lesions 
to entorhinal cortex 4'52, these authors concluded that the 
population of glutamate receptors they analyzed existed 
postsynaptically. This seems unlikely however, since at 3 
weeks, reacquisition of spines to control levels may have 
been almost complete 4,52. 
It has been argued that NMDA receptors exist on 
astrocytes and that alterations in NMDA binding follow- 
ing lesions may parallel quantitative changes in glial 
elements. In a recent study by Greenamyre and Young 22, 
quinolinic acid lesions in the rat striatum resulted in a 
92% reduction of NMDA binding. Quinoiinic acid is an 
endogenous metabolite of tryptophan that selectively 
destroys neurons 57. In the rat striatum, cell loss results in 
a marked inflammatory response with gliosis that is 
evident at 7 days after quinolinate application and 
persists up to one year 3. If the NMDA receptor complex 
exists on glial cells, then one would not have expected 
such a marked reduction in NMDA binding during a 
period of glial proliferation. 
In this study, we have shown that the NMDA receptor 
complex exists predominantly on either the cell bodies or 
dendrites of neurons intrinsic to the cortex and hippo- 
campal formation. In Alzheimer's disease, there is 
extensive loss of pyramidal neurons in both of these 
regions 49'64. Studies using the Golgi technique have 
indicated that these neurons project apical and basilar 
dendrites to precisely those layers in which NMDA 
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r ecep to r  loss is grea tes t  36'37. In A l z h e i m e r ' s  disease,  
re t rac t ion  of  dendr i t ic  spines 38"43 and cell loss 49"64 in these  
layers may  account  for  the obse rved  reduct ions  of  
N M D A  receptors .  
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